VISION-BIOMODBASE
Home >> PBPK >> Tumor, Bone, Heart / Skin, Muscle / Skin / Liver / Lung / GI, Spleen >> Expansion of Baxter model (pharmacodynamics)
Expansion of Baxter model (pharmacodynamics)
 
 
Rituxan promotes cell death via 3 putative mechanisms of action:
1.
2.
ADCC (in progress)
3.
Complement (in progress)

 

Web Adaptation & Interface Concept: Jason Lee | Research Content & Original Design: Gregory Ferl, PhD
Copyright © 2005-06, UCLA Biocybernetics
Lab